Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-09-19, Stock:JNJ, The news for the past five days is as follows:
2018-09-12: NEWS1: Geron Corp: Lost in Translation?.NEWS2: Geron Corp: Lost in Translation?.NEWS3: Geron Corp: Lost in Translation?.NEWS4: Geron: One of the Best-Performing Biotech Stocks in Past Month.
2018-09-13: NEWS1: 5 Dow Jones Stocks That Are Gaining New Ground.NEWS2: Allergan Unveils Spotlyte, Its First Digital Ventures Launch.NEWS3: Noteworthy ETF Inflows: QUAL, JNJ, V, XOM.NEWS4: Noteworthy ETF Inflows: QUAL, JNJ, V, XOM.NEWS5: City of Boston sues drugmakers over opioid epidemic.NEWS6: Johnson & Johnson Seeks EU and US Label Expansion for Darzalex.NEWS7: Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for September 14, 2018.NEWS8: Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for September 14, 2018.NEWS9: What Analysts Project for Thermo Fisher.NEWS10: Johnson & Johnson: Analyst Recommendations and Target Price.NEWS11: These 13 Stocks Have Raised Their Dividends for 50 Straight Years.NEWS12: Thermo Fisher to Acquire BDX’s Advanced Bioprocessing Business.
2018-09-14: NEWS1: Wall Street Analysts Are Mostly Positive on Merck in September.NEWS2: Pacira Shares Look Expensive, Stifel Says In Bearish Initiation.NEWS3: Pharma/Biotech Stocks to Watch This Prostate Cancer Month.NEWS4: Pharma/Biotech Stocks to Watch This Prostate Cancer Month.NEWS5: Pharma Stock Roundup: AZN's Leukemia Drug Wins FDA Nod, MRK's Keytruda in Focus.NEWS6: Pharma Stock Roundup: AZN's Leukemia Drug Wins FDA Nod, MRK's Keytruda in Focus.NEWS7: Pharma/Biotech Stocks to Watch This Prostate Cancer Month.NEWS8: Johnson & Johnson’s Recent Development in HIV.NEWS9: 5 Dow Jones Stocks That Are Gaining New Ground.NEWS10: 5 Dow Jones Stocks That Are Gaining New Ground.NEWS11: Johnson & Johnson Expands Blood Cancer Portfolio with Approval.NEWS12: Johnson & Johnson To Present At Morgan Stanley Conference; Webcast At 9:55 AM ET.NEWS13: Johnson & Johnson To Present At Morgan Stanley Conference; Webcast At 9:55 AM ET.
2018-09-17: NEWS1: Glaxo Seeks EU Approval for Two-Drug Regimen in First-Line HIV.NEWS2: Pfizer&apos;s Skin Disease Candidates Positive in Mid-Stage Study.NEWS3: J&J Talc Supplier Takes No Chances on Another Big Jury Loss.NEWS4: Why Johnson & Johnson (JNJ) Could Beat Earnings Estimates Again.NEWS5: Why Johnson & Johnson (JNJ) Could Beat Earnings Estimates Again.NEWS6: Why Johnson & Johnson (JNJ) Could Beat Earnings Estimates Again.NEWS7: Is Artificial Intelligence the Next Big Thing in Biotech?.NEWS8: Is Artificial Intelligence the Next Big Thing in Biotech?.NEWS9: Is Artificial Intelligence the Next Big Thing in Biotech?.
2018-09-18: NEWS1: Health care ETF surges toward record in a broad sector rally.NEWS2: Cronos Gets Bigger As It Partners With Ginkgo Bioworks.NEWS3: Cronos Gets Bigger As It Partners With Ginkgo Bioworks.NEWS4: Exclusive - India, U.S. closing in on package deal to remove trade irritants.NEWS5: Cronos Gets Bigger As It Partners With Ginkgo Bioworks.NEWS6: Pharma Companies Avoid $3.8 Bln In Tax Per Year, Says Oxfam.NEWS7: Pharma Companies Avoid $3.8 Bln In Tax Per Year, Says Oxfam.NEWS8: Pfizer's Skin Disease Candidates Positive in Mid-Stage Study.NEWS9: Pfizer's Skin Disease Candidates Positive in Mid-Stage Study.NEWS10: Glaxo Seeks EU Approval for Two-Drug Regimen in First-Line HIV.NEWS11: Glaxo Seeks EU Approval for Two-Drug Regimen in First-Line HIV.

Answer: Decrease